PI3K/AKT/mTOR通路
蛋白激酶B
黄芪
磷酸化
信号转导
癌症研究
生物
医学
化学
细胞生物学
病理
中医药
替代医学
作者
Tzu‐Shao Yeh,Tze‐Huan Lei,Jen‐Fang Liu,Mei‐Chich Hsu
出处
期刊:Nutrients
[Multidisciplinary Digital Publishing Institute]
日期:2022-04-17
卷期号:14 (8): 1670-1670
被引量:17
摘要
Astragalus membranaceus (AM) is classified as a high-class traditional herbal medicine, which has strengthened vitality and multifunctional pharmacological activities, but limited empirical evidence is available to support its effects in muscular hypertrophy. It evokes skeletal muscle hypertrophy by increasing anabolic pathway, which is essential to prevent sarcopenia in elderly population. In this study, we examined the effects of AM on skeletal muscle hypertrophy by focusing on the molecular mechanism. We employed an in vitro model to investigate whether AM-treated skeletal muscle, as represented by myotube C2C12 cells, was hypertrophic, and to further investigate the efficacy of AM-activated phosphorylation of PI3K/Akt/mTOR signaling that must occur prior to myotube hypertrophy. The results showed that the myotubes formed larger multinucleated myotubes with increased diameter and thickness (1.16-fold relative to control group, p < 0.05). Administration of PI3K and mTOR inhibitors abolished AM-induced muscular hypertrophy. Moreover, AM-induced PI3K-mediated myotube hypertrophy was accompanied by the activation of Akt and mTOR signaling. We concluded that the AM is a nutritional activator to enhance muscular hypertrophy by increasing PI3K/Akt/mTOR signaling phosphorylation. As the AM is effective in myotube hypertrophy, AM and its derivatives may be promising candidates for ergogenic aid to prevent sarcopenia.
科研通智能强力驱动
Strongly Powered by AbleSci AI